BIODESIX INC Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biodesix Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
  • Biodesix Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.22M, a 15.2% increase year-over-year.
  • Biodesix Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $5.89M, a 10.5% decline year-over-year.
  • Biodesix Inc annual Share-based Payment Arrangement, Expense for 2023 was $5.37M, a 9.86% decline from 2022.
  • Biodesix Inc annual Share-based Payment Arrangement, Expense for 2022 was $5.96M, a 20.6% increase from 2021.
  • Biodesix Inc annual Share-based Payment Arrangement, Expense for 2021 was $4.94M, a 33.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.89M $1.22M +$161K +15.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $5.73M $2.64M +$359K +15.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $5.37M $1.08M -$996K -48% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $6.37M $954K -$216K -18.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $6.59M $1.06M -$311K -22.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $6.9M $2.28M +$935K +69.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $5.96M $2.08M +$810K +63.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $5.15M $1.17M -$216K -15.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $5.37M $1.37M +$829K +154% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $4.54M $1.35M -$406K -23.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $4.94M $1.27M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.39M +$1.29M +1286% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $539K +$484K +880% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.75M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $100K +$55K +122% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $55K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q3 2019 $45K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.